Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
1997 pubmed

Substance P increases intracellular Ca2+ in individual rat pituitary lactotrophs, somatotrophs, and gonadotrophs.

Mau. S E SE; Witt. M R MR; Saermark. T T; Vilhardt. H H

Key Findings

  • Substance P raises intracellular calcium in lactotroph, somatotroph, and gonadotroph pituitary cells.
  • The calcium rise occurs in two phases: an internal release mediated by IP3 and a later influx through voltage‑gated calcium channels.
  • Substance P is a weaker activator of calcium signals compared to TRH, growth‑hormone‑releasing hexapeptide, and GnRH.

Practical Outcomes

  • There are no actionable takeaways for GHRP‑6 users or biohackers. The findings are limited to basic rat cell physiology and do not translate into dosing, safety, or performance recommendations for humans.

Summary

The study shows that the brain chemical substance P can cause short bursts of calcium inside certain rat pituitary cells, which are involved in hormone release. It does this in two steps: first by releasing calcium from inside the cell, then by letting calcium flow in from outside. However, this research does not involve the peptide GHRP‑6 and offers no direct guidance for human health or performance.

Abstract

The present study has investigated transients in the intracellular calcium concentration [Ca2+]i in response to substance P (SP) in single pituitary cells. SP raised [Ca2+]i in three subtypes of pituitary cells: lactotrophs, somatotrophs, and gonadotrophs. In all three cell subtypes the [Ca2+]i response to SP was amplitude-modulated and a concentration of 100 nM was necessary to elicit well pronounced two phased [Ca2+]i transients. The first phase was associated with increased generation of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) in all three cell types. In lactotrophs, the second phase, but not the first, was blunted by depletion of extracellular Ca2+ (Ca2+ free EGTA incubation buffer) and by addition of dopamine (1 microM). In somatotrophs, the second phase of the SP-induced [Ca2+]i response was inhibited by depletion of extracellular Ca2+ and by addition of somatostatin (100 nM), while the first phase was unaffected by this treatment. In gonadotrophs, the second phase, but not the first, was inhibited by the Ca2+ channel blocker methoxyverapamil and depletion of extracellular Ca2+. SP was compared with other agonists having an action on lactotrophs, somatotrophs or gonadotrophs. These experiments demonstrated that SP was a weaker agonist in terms of maximal [Ca2+]i response than thyrotropin-releasing hormone (TRH) (in lactotrophs), growth hormone-releasing hexapeptide (in somatotrophs) and GnRH (in gonadotrophs). On the basis of these results it is concluded that SP exerts direct Ca2+ mobilizing effects in single lactotrophs, somatotrophs, and gonadotrophs derived from male peripubertal rats. The first phase in SP-induced [Ca2+]i transients is likely to be brought about by inositol 1,4,5-trisphosphate-mediated Ca2+ release from internal stores while the second phase reflects an influx of calcium through voltage-gated calcium channels.

Study Information

Provider

pubmed

Year

1997

Date

1997-02-07T00:00:00.000Z

DOI

10.1016/s0303-7207(96)03988-3